HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Sephora's Digital UK Return Clicks With Feelunique

Executive Summary

French firm Sephora returns to UK with online sale after 17 years following 2021 purchase of beauty e-commerce firm Feelunique. Sephora’s offering Feelunique line among 30 brands including Sephora Collections.

You may also be interested in...

IPAR Sales Grow 26% On 'Premiumization' Streak, As Symrise Earnings Stumble Over Production Issues: Briefs

New York-based Inter Parfums, Inc. says continued “premiumization’ trends in fragrance helped drive its sales up 26% in the second quarter, while German company Symrise AG’s two recent purchases in the fragrance space added 15m to sales in the first-half of the year. Separately, Revlon announces interim CEO as head Debra Perelman steps down.

Kohl’s Anticipates $2Bn In Sales By 2025 From ‘Game Changing’ Sephora Installations

Kohl’s reports its Sephora at Kohl’s beauty store-within-store has brought 1 million new customers – largely young and diverse – since it launched last August, with $2bn in sales targeted by 2025.

Target Corp.'s ‘Clean’ Marketing Challenged In Consumer Class Action

The mega-retailer is defending a proposed class action in Minnesota federal court over its ‘Target Clean’ marketing and label, which it has awarded "independently" to around 4,000 products in its stores. Consumer plaintiffs allege some offerings contain ingredients on the program's “formulated without” list, as well as other hazardous substances that ought not be in clean products. Pending litigation against Sephora stands to be influential.


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts